Thomas, McNerney & Partners

Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding. Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.